UNSPSC 51183620: Pramlintide acetate

This classification denotes an anti-diabetic agent with the molecular formula C171H267N51O53S2.C2H4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 726I6TE06G. European Medicines Agency schedules pramlintide acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12564MIG. The term pramlintide acetate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule pramlintide acetate under HS 29349990 and SITC 51579.

As of Q4 2014, PRAMLINTIDE ACETATE remains US FDA's Preferred Term for this commodity. Pramlintide acetate bears US NLM identifiers UMLS ID C1174780 and NCI Concept Code C61902.

UNSPSC 51183620 Pramlintide acetate is a Commodity code identifying a specific pharmaceutical product, and recent state and local procurement activity under it centers on multi-source generic pharmaceutical supply agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, recently issued a Request for Proposal to establish multiple contracts for generic pharmaceuticals and over-the-counter products to be distributed across participating state and local government facilities in Minnesota and Oregon. The procurement seeks manufacturers to supply comprehensive pricing for identified pharmaceutical products with specific National Drug Codes (NDC), including pramlintide acetate formulations, with vendors required to certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). Products must be supplied through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — and vendors must maintain contractual relationships with at least two of the three with chargeback systems in place. Insurance requirements include commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000.

The MMCAP solicitation (S1070000015802) issued January 20, 2026, with proposals due March 26, 2026, covers multi-state cooperative purchasing across Minnesota and participating jurisdictions in Oregon and beyond. Evaluation criteria emphasize price competitiveness (75 percent) alongside fixed pricing for the contract term (10 percent), EDI capability (5 percent), compliance with administrative fee data format requirements (5 percent), and agreement to a 3 percent administrative fee (5 percent). The contract term is two years for new responders with optional extensions at MMCAP's sole discretion, with awarded contracts effective July 1, 2026. Specific award values are not disclosed in the solicitation materials; vendors should expect to comply with performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting, missed onboarding timelines, or improper class-of-trade denials.